Aptar Digital and Gerresheimer Partner To Aid Patients in Cancer therapy

The innovative systems and solutions provider Gerresheimer, a global partner to the pharmaceutical, biotech, and cosmetics industries, and Aptar Digital Health, a leader in software as a medical device (SaMD), digital patient support programs (PSPs), and disease management solutions, have announced a new partnership to develop a customized solution to support patients and healthcare professionals in managing cancer therapy. 

By connecting Aptar Digital Health's proprietary SaMD platform with Gx SensAir, Gerresheimer's on-body device for the subcutaneous delivery of large biologics molecules, this integrated solution is intended to improve overall treatment adherence and clinical outcomes. More specifically, it aims to make remote patient monitoring easier, and facilitate the onboarding of patients to new therapies, helping them to better manage adverse effects, as per pharmabiz.      Both businesses think that cutting-edge digital platforms and subcutaneous injectable tools can enhance the oncology patient experience. Pharmaceutical companies see this partnership as a chance to address potential obstacles such treatment interruptions or discontinuations due to unpleasant effects or administration concerns, and to provide a more patient-centric solution. Additionally, this method will facilitate the switch from intravenous to subcutaneous delivery of cancer medications.

“We are honored to collaborate with Gerresheimer, a global industrial partner in drug delivery devices,” stated Sai Shankar, President of Aptar Digital Health. “By combining our collective and proprietary expertise in device and software engineering, we believe this collaboration has the potential to deliver innovative solutions for patients, healthcare providers and the healthcare industry.”

“Combining our efforts opens up new exciting possibilities for optimizing the respective drug therapy and improving the quality of life for cancer patients,” said Daniel Diezi, Vice President Digitalization & New Business Models at Gerresheimer. “This collaboration in oncology will lay the groundwork for Aptar Digital Health and Gerresheimer to potentially expand into other therapeutic areas in the future."